1. Home
  2. CSBR vs MCHX Comparison

CSBR vs MCHX Comparison

Compare CSBR & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

HOLD

Current Price

$6.03

Market Cap

91.0M

Sector

Health Care

ML Signal

HOLD

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

N/A

Current Price

$1.57

Market Cap

76.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
CSBR
MCHX
Founded
1985
2003
Country
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
91.0M
76.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CSBR
MCHX
Price
$6.03
$1.57
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
6.2K
24.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.84
N/A
Revenue Next Year
$11.51
$6.70
P/E Ratio
$33.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.59
$1.26
52 Week High
$11.16
$2.31

Technical Indicators

Market Signals
Indicator
CSBR
MCHX
Relative Strength Index (RSI) 36.31 34.24
Support Level $6.53 $1.59
Resistance Level $6.34 $1.62
Average True Range (ATR) 0.39 0.07
MACD -0.13 -0.01
Stochastic Oscillator 6.07 10.00

Price Performance

Historical Comparison
CSBR
MCHX

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

Share on Social Networks: